Through a special issue of shares, Investor Growth Capital will become the principle owner of the Uppsala-based medical technology company Doxa. Doxa develops new biomaterial for medical use. Since 2002, work has concentrated on rapidly growing field of orthopaedics. The infusion of capital will finance continued development of their biomaterial.
Vinge acted as advisor to Investor Growth Capital. Vinge representatives included Johan Winnerblad and Tom Zachrisson.
